In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...

Like all drugs that interfere with blood clotting, ticagrelor increases patients' risk of having a bleeding episode, especially during urgent surgery or another type of invasive procedure ...

The prothrombin complex concentrate costs more than plasma, but may pay dividends by way of fewer adverse events.

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

The Medical Protection Society says lessons can be learned from the case of a patient given an incorrect risk score for ...